Skip to content

Mesa Laboratories MLAB Free cash flow yield

Free cash flow yield at other companies

3M logo
3MMMM
2.7%+2.6pp
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.7%+0.1pp
Danaher logo
DanaherDHR
3.9%+0.6pp
STERIS logo
STERISSTE
4.5%+1.0pp
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
4.7%-0.5pp
Charles River Laboratories logo
Charles River LaboratoriesCRL
4.6%-2.7pp

Other financials

Income statement

See full
Revenue$63.7M+2.6%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$3.6M+317%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$26.9M-1.4%
Total debt$78.7M-53.1%
Total equity$186.2M+16.5%
Total assets$427.7M-1.3%

Cash flow

See full
Operating cash flow$14.0M+10.2%
CapEx$417.0K-44.9%
Free cash flow$13.5M+13.7%

Valuation

See full
Market cap$542.27M+3.7%
Enterprise value$594.05M-10.4%
P/S2.2×0.0×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin15.9%-1.8pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.7×+1.1×

Where this comes from

Calculated from Mesa Laboratories’s reported figures.

Based on trailing twelve months.

The official record: Mesa Laboratories’s 10-K, filed June 3, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mesa Laboratories's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mesa Laboratories's free cash flow yield?
Mesa Laboratories (MLAB) reported free cash flow yield of 8.1% in Q1 2026.
How has Mesa Laboratories's free cash flow yield changed year-over-year?
Mesa Laboratories's free cash flow yield increased by 22.8% year-over-year, from 6.6% to 8.1%.
What is the long-term trend for Mesa Laboratories's free cash flow yield?
Over 5 years (2021 to 2026), Mesa Laboratories's free cash flow yield has grown at a 23.7% compound annual growth rate (CAGR), from 2.8% to 8.1%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.